Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGM:PAHC
NasdaqGM:PAHCPharmaceuticals

A Look At Phibro Animal Health (PAHC) Valuation After A Strong 1 Year Total Return

What stands out about Phibro Animal Health right now Phibro Animal Health (PAHC) has caught investor attention after a strong 1 year total return of 135.9%, alongside reported annual revenue of US$1.46b and net income of US$92.09 million. See our latest analysis for Phibro Animal Health. The current share price of US$49.47 reflects a mixed recent pattern, with a 7 day share price return of 3.23% and a 90 day share price return of 23.21%, alongside a 1 year total shareholder return of 135.9%...
NYSE:XPEV
NYSE:XPEVAuto

Is XPeng (NYSE:XPEV) Pricing Reflect Long Term Value After Recent Share Rebound

If you are wondering whether XPeng's current share price lines up with its underlying value, you are not alone. This article is going to focus squarely on that question. XPeng shares last closed at US$19.97, with recent returns of 15.3% over 7 days and 10.3% over 30 days. Year to date the stock shows a 2.3% decline and a 15.8% decline over 1 year, compared with a very large gain over 3 years and a 46.7% decline over 5 years. These swings have kept XPeng on many investors' watchlists, even as...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

Is CoStar Group (CSGP) Pricing Look Attractive After Recent Share Price Slide?

If you are wondering whether CoStar Group's current share price really reflects what the business is worth, you are not alone. This article is built to help you frame that question clearly. With the stock at US$43.63 and returns of a 9.8% decline over 7 days, an 8.9% decline over 30 days and a 33.6% decline year to date, many investors are reassessing the balance between potential upside and risk. Recent coverage of CoStar Group has focused on its role as a key player in real estate...
ASX:WOR
ASX:WORConstruction

Director Grill Lifts Worley Stake As Valuation Screens Undervalued

Worley (ASX:WOR) director John Michael Grill has increased his indirect shareholding via an on market acquisition. The transaction reflects a larger personal stake in the company by a key board member. The move points to insider confidence and closer alignment with other shareholders. Worley, through its engineering and professional services, is closely tied to long term energy, resources and infrastructure projects. As the sector adapts to changing customer demands and project profiles,...
NYSE:GDDY
NYSE:GDDYIT

Assessing GoDaddy (GDDY) Valuation After Recent Share Price Weakness

GoDaddy stock performance snapshot GoDaddy (GDDY) has drawn attention after a period of weak share performance, with the stock showing negative returns over the past week, month, past 3 months and year, while longer term returns remain positive. See our latest analysis for GoDaddy. At a share price of $81.22, GoDaddy has seen momentum fade recently, with a weaker 7 day and 90 day share price return sitting alongside a positive 3 year total shareholder return. This points to a mixed picture of...
NasdaqGS:FITB
NasdaqGS:FITBBanks

Evaluating Fifth Third (FITB) Valuation After Recent Share Price Weakness And Mixed Return Signals

What recent returns suggest about Fifth Third Bancorp Fifth Third Bancorp (FITB) has seen mixed recent performance, with a 0.4% decline over the past day, an 8.2% slide over the past week, and an 18.4% drop over the past month. Over longer periods, the stock shows a different picture, with a 9% decline year to date, a 16.7% total return over the past year, a very large 3-year total return, and a 36.4% total return over 5 years. See our latest analysis for Fifth Third Bancorp. At a share price...
NYSE:WM
NYSE:WMCommercial Services

The Bull Case For Waste Management (WM) Could Change Following Dividend Hike And Insider Stock Sales

Earlier this month, Waste Management declared a quarterly cash dividend of US$0.945 per share, payable on March 27, 2026, to shareholders of record as of March 13, 2026, even as its fourth-quarter 2025 earnings and revenue came in slightly below analyst expectations. The news was accompanied by sizeable stock sales from senior executives, including the President and COO and the Chief Accounting Officer, drawing attention to insider activity at a time when the company is already viewed as...
NYSE:ZWS
NYSE:ZWSBuilding

Assessing Zurn Elkay Water Solutions (ZWS) Valuation After Recent Share Price Pullback

Recent performance snapshot Zurn Elkay Water Solutions (ZWS) has drawn attention after a period of mixed share performance, with the stock showing negative moves over the past week, month, past 3 months, and year to date, alongside a positive 1 year total return. See our latest analysis for Zurn Elkay Water Solutions. At a share price of US$45.73, Zurn Elkay Water Solutions has seen short term momentum fade, with a 1 month share price return decline of 11.29%. However, its 1 year total...
NYSE:DQ
NYSE:DQSemiconductor

Is Daqo New Energy (DQ) Pricing Reflect Its Recent Volatility And Conflicting Valuation Signals

If you are wondering whether Daqo New Energy is priced attractively today, the key question is how its current share price lines up with its underlying business value. The stock last closed at US$23.11, with returns of 4.3% over 7 days, a 10.5% decline over 30 days, a 22.1% decline year to date, and a 21.2% gain over 1 year that sits against much weaker 3 year and 5 year returns of 49.4% and 70.8% declines. Recent price moves have been shaped by ongoing sector wide discussion around solar...
ENXTAM:PHIA
ENXTAM:PHIAMedical Equipment

Assessing Philips (ENXTAM:PHIA) Valuation After Recent Share Price Pullback

Recent performance snapshot Without a specific headline event driving attention today, Koninklijke Philips (ENXTAM:PHIA) may still interest you if you are tracking healthcare names with mixed short term and longer term return profiles. The stock shows a 0.9% decline over the past day and a 2.0% decline over the past week, with a larger 8.4% drop over the past month, while the past 3 months reflect a 7.3% gain. See our latest analysis for Koninklijke Philips. At a share price of €24.41, the...
TSXV:ODV
TSXV:ODVMetals and Mining

Does Osisko Development's (TSXV:ODV) Cariboo Restart Reframe Its De-Risking Strategy or Execution Risk?

Osisko Development Corp. recently reported that it has safely resumed planned surface and underground activities at the Cariboo Gold Project in British Columbia, after a temporary suspension following an isolated tragic incident in January 2026. The update highlights meaningful on-the-ground progress, including near-complete commissioning of a water treatment plant, over 2.1 kilometres of underground development, multiple active drill programs, and expanded camp capacity to support future...
TSX:AC
TSX:ACAirlines

A Look At Air Canada (TSX:AC) Valuation After War And Strike Disruptions

Why Air Canada (TSX:AC) is suddenly in focus Air Canada (TSX:AC) is back on investors’ radar after two pressure points hit airlines at once: rising concerns around the war in Iran and a Barbados air traffic control strike that disrupted one of its international flights. See our latest analysis for Air Canada. Despite product upgrades and fleet renewal news, recent pressure on airline stocks has weighed on Air Canada. The company has seen a 30 day share price return of a 15.21% decline and a...
TSE:6702
TSE:6702IT

Fujitsu’s AI Infrastructure Alliance With Arrcus and 1Finity Could Be A Game Changer For Fujitsu (TSE:6702)

In early March 2026, Arrcus announced a collaboration with Fujitsu and 1Finity to combine FUJITSU-MONAKA Arm-based CPUs, ArcOS software-defined networking, and high-speed optical interconnects into a secure, energy-efficient infrastructure for distributed AI workloads from edge inference to large-scale training. This partnership highlights Fujitsu’s push to align compute, networking, and optical transport for emerging Physical and enterprise AI use cases such as smart factories, robotics,...
TSX:SIS
TSX:SISMachinery

Assessing Savaria (TSX:SIS) Valuation After Full Year 2025 Earnings And Mobility Demand Trends

Savaria (TSX:SIS) has drawn fresh attention after reporting full year 2025 results, with sales of CA$913.53 million and net income of CA$68.77 million, alongside higher earnings per share from continuing operations. See our latest analysis for Savaria. The share price has eased in the short term, with a 1-day share price return of a 1.67% decline and a 7-day share price return of a 2.82% decline. However, a 90-day share price return of 13.61% and a 1-year total shareholder return of 54.30%...
NYSE:MWA
NYSE:MWAMachinery

A Look At Mueller Water Products (MWA) Valuation After Recent Share Price Consolidation

Recent performance snapshot Mueller Water Products (MWA) has drawn fresh attention after a mixed stretch in its share price, with a recent 0.4% daily gain contrasting with a 0.7% decline over the past week and a 5.8% pullback over the past month. Even so, the stock shows an 11.0% return over the past 3 months and a 15.9% gain year to date, alongside a 2.9% total return over the past year. This has prompted a closer look at how these moves line up with the company’s fundamentals. See our...
NYSE:BV
NYSE:BVCommercial Services

Is It Time To Reassess BrightView Holdings (BV) After Recent Commercial Services Repricing

If you are wondering whether BrightView Holdings is attractively priced or just a value trap, you are in the right place to unpack what the current share price really reflects. The stock last closed at US$11.81, with returns of 7.2% decline over 7 days, 15.5% decline over 30 days, a 6.3% decline year to date, a 10.9% decline over 1 year, a 102.6% gain over 3 years and a 30.4% decline over 5 years. Taken together, this gives you a mixed picture of how sentiment has shifted over different...
NasdaqGS:LULU
NasdaqGS:LULULuxury

Has The Slide In Lululemon (LULU) Opened Up A Valuation Opportunity Now

If you have been wondering whether lululemon athletica's recent share price slide has made the stock look more interesting on value, this breakdown is designed to give you a clear, numbers first view. The share price closed at US$157.78, with returns of 7.3% decline over 7 days, 10.3% decline over 30 days, 25.2% decline year to date and 49.3% decline over 1 year. The 3 year and 5 year returns are 46.5% decline and 48.9% decline respectively. Recent moves in the stock have been set against an...
ENXTPA:AM
ENXTPA:AMAerospace & Defense

Is It Time To Reassess Dassault Aviation (ENXTPA:AM) After Its Strong Multi Year Share Price Run?

If you are wondering whether Dassault Aviation société anonyme is priced attractively today, it helps to step back from the headlines and look closely at what the numbers are actually saying about its value. The stock recently closed at €348.80, with returns of 4.5% over 7 days, 8.5% over 30 days, 24.4% year to date, 15.1% over 1 year and 109.0% over 3 years, which naturally raises questions about how much of this performance is already reflected in the current share price. Recent coverage...
NYSE:STNG
NYSE:STNGOil and Gas

Assessing Scorpio Tankers (STNG) Valuation After Recent Share Price Pullback And Undervaluation Estimate

What Scorpio Tankers’ Recent Performance Signals for Investors Scorpio Tankers (STNG) has quietly drawn attention after a mixed stretch in the share price, with a 1 day return of 1.53% and a 13.61% decline over the past week. Over the past month the stock shows a 5.01% decline, even as the past 3 months reflect a 27.70% gain and the 1 year total return stands at 73.15%. This puts recent moves into a longer term context. See our latest analysis for Scorpio Tankers. With the share price at...
NYSE:MCK
NYSE:MCKHealthcare

Is It Too Late To Consider McKesson (MCK) After Strong Multi Year Share Price Gains

If you are looking at McKesson and wondering whether the current share price lines up with its underlying value, this article is going to walk you through the key numbers that matter. The stock last closed at US$940.91, with returns of 2.4% over 7 days, a 1.3% decline over 30 days, 14.3% year to date, 45.2% over 1 year and 181.2% over 3 years. These figures raise fair questions about how much of the story is already reflected in the price. Recent coverage around McKesson has focused on its...
NasdaqGS:TRIN
NasdaqGS:TRINCapital Markets

Assessing Trinity Capital (TRIN) After Recent Pullback And Strong Valuation Signals

If you are wondering whether Trinity Capital's current share price reflects its true worth, you are not alone. This article is set up to help you look past the headline numbers and into what the valuation actually implies. The stock last closed at US$14.42, with returns of 7.9% over 1 year and much stronger gains over 3 and 5 years. However, the last 7 and 30 days show declines of 3.3% and 8.8% that may have shifted how investors see the balance between opportunity and risk. Recent coverage...
ASX:MSB
ASX:MSBBiotechs

Is Mesoblast's New Clinical Leader Quietly Reframing Its Commercialization Story for Cell Therapies (ASX:MSB)?

Earlier this week, Mesoblast Limited created a new senior leadership role and appointed Teresa Montagut MD, PhD as Head of Clinical Development and Medical Affairs, reporting to Chief Medical Officer Dr. Eric Rose, to lead medical affairs, clinical collaborations and investigator-initiated trials across its cell therapy programs. By bringing in a physician-scientist with extensive experience in early pipeline studies and investigator-sponsored research at major biopharmaceutical companies,...
NasdaqGS:MTCH
NasdaqGS:MTCHInteractive Media and Services

Assessing Match Group (MTCH) Valuation As Growth Headwinds Persist And Bumble Pushes Forward With AI

Recent updates around Match Group (MTCH) have centered on declining payers, lower average revenue per user and flat sales expectations, just as rival Bumble pushes ahead with AI-focused product changes and early positive feedback. See our latest analysis for Match Group. The latest updates appear to be weighing on confidence, with Match Group’s share price down 7.23% over 90 days and its 5 year total shareholder return down 79.24%, even though the 1 year total shareholder return is slightly...
NYSE:HAE
NYSE:HAEMedical Equipment

Haemonetics Expands Hospital Portfolio As Investors Weigh Growth And Valuation

Haemonetics (NYSE:HAE) is expanding its product portfolio in the Hospital division with new technology and acquisitions. The company has fully transitioned from legacy PCS2 plasma collection devices to its NexSys PCS system with Persona Technology. Recent purchases of Attune Medica and OpSens add new capabilities in hospital and interventional cardiology settings. For you as an investor, this shift is about more than one product line. Haemonetics operates across blood management and...